These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30333303)

  • 1. Exploring the cardiac response to injury in heart transplant biopsies.
    Halloran PF; Reeve J; Aliabadi AZ; Cadeiras M; Crespo-Leiro MG; Deng M; Depasquale EC; Goekler J; Jouven X; Kim DH; Kobashigawa J; Loupy A; Macdonald P; Potena L; Zuckermann A; Parkes MD
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System.
    Halloran PF; Potena L; Van Huyen JD; Bruneval P; Leone O; Kim DH; Jouven X; Reeve J; Loupy A
    J Heart Lung Transplant; 2017 Nov; 36(11):1192-1200. PubMed ID: 28662985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival.
    Halloran PF; Madill-Thomsen K; Aliabadi-Zuckermann AZ; Cadeiras M; Crespo-Leiro MG; Depasquale EC; Deng M; Gökler J; Hall S; Jamil A; Kim DH; Kobashigawa J; Macdonald P; Melenovsky V; Patel J; Potena L; Shah K; Stehlik J; Zuckermann A
    Am J Transplant; 2024 Aug; 24(8):1414-1426. PubMed ID: 38527588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes.
    Halloran PF; Madill-Thomsen K; Aliabadi-Zuckermann AZ; Cadeiras M; Crespo-Leiro MG; Depasquale EC; Deng M; Gökler J; Kim DH; Kobashigawa J; Macdonald P; Potena L; Shah K; Stehlik J; Zuckermann A
    J Heart Lung Transplant; 2022 Mar; 41(3):334-344. PubMed ID: 34548198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features.
    Halloran PF; Venner JM; Famulski KS
    Am J Transplant; 2017 Jul; 17(7):1754-1769. PubMed ID: 28101959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms.
    Parkes MD; Aliabadi AZ; Cadeiras M; Crespo-Leiro MG; Deng M; Depasquale EC; Goekler J; Kim DH; Kobashigawa J; Loupy A; Macdonald P; Potena L; Zuckermann A; Halloran PF
    J Heart Lung Transplant; 2019 Jun; 38(6):636-646. PubMed ID: 30795962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.
    Loupy A; Duong Van Huyen JP; Hidalgo L; Reeve J; Racapé M; Aubert O; Venner JM; Falmuski K; Bories MC; Beuscart T; Guillemain R; François A; Pattier S; Toquet C; Gay A; Rouvier P; Varnous S; Leprince P; Empana JP; Lefaucheur C; Bruneval P; Jouven X; Halloran PF
    Circulation; 2017 Mar; 135(10):917-935. PubMed ID: 28148598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables.
    Mengel M; Sis B; Kim D; Chang J; Famulski KS; Hidalgo LG; Einecke G; de Freitas DG; Tymchak W; Burton J; Halloran PF
    Am J Transplant; 2010 Sep; 10(9):2105-15. PubMed ID: 20883545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study.
    Madill-Thomsen K; Abouljoud M; Bhati C; Ciszek M; Durlik M; Feng S; Foroncewicz B; Francis I; Grąt M; Jurczyk K; Klintmalm G; Krasnodębski M; McCaughan G; Miquel R; Montano-Loza A; Moonka D; Mucha K; Myślak M; Pączek L; Perkowska-Ptasińska A; Piecha G; Reichman T; Sanchez-Fueyo A; Tronina O; Wawrzynowicz-Syczewska M; Więcek A; Zieniewicz K; Halloran PF
    Am J Transplant; 2020 Aug; 20(8):2156-2172. PubMed ID: 32090446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-center retrospective clinicopathologic study of endomyocardial biopsies after heart transplant at Baskent University Hospital in Ankara, 1993-2014.
    Terzi A; Sezgin A; Tunca Z; Deniz E; Ayva EŞ; Haberal Reyhan N; Müderrisoğlu H; Özdemir BH
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():346-51. PubMed ID: 25894188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular assessment of rejection and injury in lung transplant biopsies.
    Halloran KM; Parkes MD; Chang J; Timofte IL; Snell GI; Westall GP; Hachem R; Kreisel D; Trulock E; Roux A; Juvet S; Keshavjee S; Jaksch P; Klepetko W; Halloran PF
    J Heart Lung Transplant; 2019 May; 38(5):504-513. PubMed ID: 30773443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricuspid valve injury after heart transplantation due to endomyocardial biopsy: an analysis of 3550 biopsies.
    Fiorelli AI; Coelho GH; Aiello VD; Benvenuti LA; Palazzo JF; Santos Júnior VP; Canizares B; Dias RR; Stolf NA
    Transplant Proc; 2012 Oct; 44(8):2479-82. PubMed ID: 23026624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
    Dixon V; Macauley C; Burch M; Sebire NJ
    Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Molecular Microscope Diagnostic System: Assessment of Rejection and Injury in Heart Transplant Biopsies.
    Halloran PF; Madill-Thomsen KS
    Transplantation; 2023 Jan; 107(1):27-44. PubMed ID: 36508644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-expression profiling for rejection surveillance after cardiac transplantation.
    Pham MX; Teuteberg JJ; Kfoury AG; Starling RC; Deng MC; Cappola TP; Kao A; Anderson AS; Cotts WG; Ewald GA; Baran DA; Bogaev RC; Elashoff B; Baron H; Yee J; Valantine HA;
    N Engl J Med; 2010 May; 362(20):1890-900. PubMed ID: 20413602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring personalized treatment for cardiac graft rejection based on a four-archetype analysis model and bioinformatics analysis.
    Shi H; Yuan M; Cai J; Shi J; Li Y; Qian Q; Dong Z; Pan G; Zhu S; Wang W; Zhou J; Zhou X; Liu J
    Sci Rep; 2024 Mar; 14(1):6529. PubMed ID: 38499711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomyocardial biopsy in pediatric heart transplant recipients: a useful exercise? (Analysis of 1,169 biopsies).
    Wagner K; Oliver MC; Boyle GJ; Miller SA; Law YM; Pigula F; Webber SA
    Pediatr Transplant; 2000 Aug; 4(3):186-92. PubMed ID: 10933318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinicopathological endomyocardial biopsy analysis in cardiac transplant recipients due to end-stage heart failure].
    Li L; Zhao H; Wang HY; Lü FY; Liu L; Wang QZ; Si WX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):819-21. PubMed ID: 17217692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
    Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.